Daddacha, W.; Monroe, D.; Carver, K.; Usoro, E.R.; Alptekin, A.; Xu, H.; Osuka, S.; Arbab, A.S.; Sakamuro, D.
Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination. Cancers 2022, 14, 4490.
https://doi.org/10.3390/cancers14184490
AMA Style
Daddacha W, Monroe D, Carver K, Usoro ER, Alptekin A, Xu H, Osuka S, Arbab AS, Sakamuro D.
Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination. Cancers. 2022; 14(18):4490.
https://doi.org/10.3390/cancers14184490
Chicago/Turabian Style
Daddacha, Waaqo, Dominique Monroe, Kristen Carver, Edidiong R. Usoro, Ahmet Alptekin, Hongyan Xu, Satoru Osuka, Ali S. Arbab, and Daitoku Sakamuro.
2022. "Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination" Cancers 14, no. 18: 4490.
https://doi.org/10.3390/cancers14184490
APA Style
Daddacha, W., Monroe, D., Carver, K., Usoro, E. R., Alptekin, A., Xu, H., Osuka, S., Arbab, A. S., & Sakamuro, D.
(2022). Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination. Cancers, 14(18), 4490.
https://doi.org/10.3390/cancers14184490